Analyst upgrades: ALL, LXK, RFMD, Q and WBSN
Posted Aug 14th 2007 11:12AM by Kevin Shult
Filed under: Before the Bell, Analyst Reports, Analyst Upgrades and Downgrades, Good news, Allstate Corp (ALL), Qwest Communications Intl (Q), Stocks to Buy
MOST NOTEWORTHY: Websence (WBSN), RF Micro Devices (RFMD), Fiserv (FISV), Qwest (Q), and OSI Pharma (OSIP) were today's noteworthy upgrades:
- JP Morgan upgraded shares of Websence (NASDAQ: WBSN) to Overweight from Underweight ahead of the renewal period starting in the December quarter and expects this momentum to drive shares higher.
- RF Micro Devices (NASDAQ: RFMD) was raised to Buy from Hold at Citigroup, who said the Sirenza Microdevices (SMDI) deal gives the company its first real prospect for gross margin expansion in years.
- Matrix USA upgraded Fiserv (NASDAQ: FISV) to Buy from Sell, and expects the company to benefit from the Checkfree (CKFR) acquisition.
- Lehman upgraded shares of Qwest (NYSE: Q) to Overweight from Equal Weight, citing the hiring of industry veteran Ed Mueller as CEO. The firm believes the new CEO removes an overhang and could lead to a change in strategic direction and significantly increase capital spending.
- JP Morgan upgraded OSI Pharma (NASDAQ: OSIP) to Overweight from Underweight based on valuation and upcoming catalysts for Tarceva that should be seen in the next year...
OTHER UPGRADES:
- UBS upgraded Allstate (NYSE: ALL) to Neutral from Sell.
- FTN Midwest upgraded shares of Lexmark (NYSE: LXK) to Neutral from Sell.
- Hambrecht upgraded NetGear (NASDAQ: NTGR) to Buy from Hold.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required). Tags: all, allstate, analyst, checkfree, ckfr, fiserv, hansen medical, HansenMedical, hnsn, leap, lexmark, lxk, micro, osi pharma, osip, OsiPharma, qwest, rating, rfmd, sirenza, smdi, tarceva, upgrade, wbsn, websence
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
